Glycated albumin modifies platelet adhesion and aggregation responses

Area of Science:

• Biochemistry
• Vascular Biology
• Hematology

Background:

• Diabetic vasculature contributes to cardiovascular disease (CVD) via advanced glycation end products (AGEs).
• AGEs impact endothelial cells and platelets, but specific platelet pathways affected by AGEs remain unclear.
• Understanding AGEs' effects on platelet function is crucial for CVD prevention in diabetes.

Purpose of the Study:

• To investigate the impact of AGEs on specific platelet pathways relevant to CVD.
• To determine if the extent of glycation influences AGEs' effects on platelet function.
• To elucidate the relationship between AGE-induced receptor expression and altered platelet activity.

Main Methods:

• Platelets were incubated with reversibly or irreversibly glycated albumin.
• Time-course analysis of adhesion and aggregation agonist receptor expression was performed.
• Optical platelet aggregometry assessed platelet functional activity post-AGE exposure.

Main Results:

• Glycated albumin significantly enhanced platelet adhesion and aggregation.
• Dense body secretion and intracellular calcium concentration increased, particularly with irreversibly glycated albumin.
• Functional aggregation correlated with receptor expression, indicating AGE-induced alterations in receptor sensitivity.

Conclusions:

• Diabetic conditions render platelets more susceptible to activation and aggregation due to enhanced receptor expression.
• AGEs promote platelet hyper-reactivity, potentially exacerbating CVD development.
• The extent of glycation influences the degree of platelet activation by AGEs.